{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:18:46Z","timestamp":1783606726226,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972720"],"award-info":[{"award-number":["81972720"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>High CDX2 expression frequently indicates better survival in stage II-III colon cancer; nevertheless, it is linked to decreased systemic chemotherapy response rates. Ferroptosis, commonly recognized as an iron-dependent oxidative death, is increasingly believed as a disease-modifying mechanism. The purpose of this study is to determine the role of ferroptosis in CDX2-mediated colon cancer chemical resistance. Mechanistically, CDX2-mediated NUPR1 transcription prevents ferroptotic cell death by reducing iron accumulation and oxidative stress damage. Depletion of NUPR1 counteracted the effect of CDX2 overexpression in terms of ferroptosis resistance, whereas transfection-enforced re-expression of NUPR1 restores ferroptosis resistance in CDX2-deficient cells. Genetic or pharmacological blockage of CDX2-NUPR1 axis improved the potential of ferroptosis agonists to combat colon cancer in preclinical mouse models. Our study uncovered a novel molecular mechanism by which CDX2 imparts ferroptosis resistance to colon cancer. Blockage of NUPR1 might be as a potential therapeutic strategy for CDX2-positive stage II-III colon cancer.<\/jats:p>","DOI":"10.1038\/s41419-026-08412-x","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:35:35Z","timestamp":1773318935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CDX2 confers ferroptosis resistance in stage II-III colon cancer via upregulation of NUPR1"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2119-3713","authenticated-orcid":false,"given":"Junhui","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchao","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenye","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zepeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0178-5551","authenticated-orcid":false,"given":"Xuejun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"8412_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A cancer J clinicians. 2021;71:209\u201349.","journal-title":"CA: A cancer J clinicians"},{"key":"8412_CR2","doi-asserted-by":"publisher","first-page":"vi64","DOI":"10.1093\/annonc\/mdt354","volume":"24","author":"R Labianca","year":"2013","unstructured":"Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandal\u00e0 M, Cervantes A, et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol: J Eur Soc Med Oncol. 2013;24:vi64\u201372.","journal-title":"Ann Oncol: J Eur Soc Med Oncol"},{"key":"8412_CR3","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO.2010.34.3426","volume":"29","author":"ES O\u2019Connor","year":"2011","unstructured":"O\u2019Connor ES, Greenblatt DY, LoConte NK, Gangnon RE, Liou JI, Heise CP, et al. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol: J Am Soc Clin Oncol. 2011;29:3381\u20138.","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"},{"key":"8412_CR4","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.1073\/pnas.96.13.7318","volume":"96","author":"F Beck","year":"1999","unstructured":"Beck F, Chawengsaksophak K, Waring P, Playford RJ, Furness JB. Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc Natl Acad Sci USA. 1999;96:7318\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8412_CR5","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1158\/1078-0432.CCR-09-0401","volume":"15","author":"Y Baba","year":"2009","unstructured":"Baba Y, Nosho K, Shima K, Freed E, Irahara N, Philips J, et al. Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer. Clin Cancer Res: Off J Am Assoc Cancer Res. 2009;15:4665\u201373.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"8412_CR6","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1097\/PAS.0b013e31829ab1c1","volume":"37","author":"JH Kim","year":"2013","unstructured":"Kim JH, Rhee YY, Bae JM, Cho NY, Kang GH. Loss of CDX2\/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer. Am J Surg Pathol. 2013;37:1532\u201341.","journal-title":"Am J Surg Pathol"},{"key":"8412_CR7","doi-asserted-by":"publisher","first-page":"E3196","DOI":"10.1073\/pnas.1206004109","volume":"109","author":"K Salari","year":"2012","unstructured":"Salari K, Spulak ME, Cuff J, Forster AD, Giacomini CP, Huang S, et al. CDX2 is an amplified lineage-survival oncogene in colorectal cancer. Proc Natl Acad Sci USA. 2012;109:E3196\u20133205.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8412_CR8","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1056\/NEJMc1602584","volume":"374","author":"RR Coebergh van den Braak","year":"2016","unstructured":"Coebergh van den Braak RR, Martens JW, Ijzermans JN. CDX2 as a Prognostic Biomarker in Colon Cancer. N Engl J Med. 2016;374:2182.","journal-title":"N Engl J Med"},{"key":"8412_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, et al. A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"},{"key":"8412_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8412_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.molmed.2020.08.010","volume":"27","author":"M Conrad","year":"2021","unstructured":"Conrad M, Lorenz SM, Proneth B. Targeting Ferroptosis: New Hope for As-Yet-Incurable Diseases. Trends Mol Med. 2021;27:113\u201322.","journal-title":"Trends Mol Med"},{"key":"8412_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Tan H, Daniels JD, Zandkarimi F, Liu H, Brown LM, et al. Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model. Cell Chem Biol. 2019;26:623\u201333.e629.","journal-title":"Cell Chem Biol"},{"key":"8412_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"MA Badgley","year":"2020","unstructured":"Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Sci (N Y, NY). 2020;368:85\u20139.","journal-title":"Sci (N Y, NY)"},{"key":"8412_CR14","doi-asserted-by":"crossref","unstructured":"Gao W, Wang X, Zhou Y, Wang X & Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Sig Transduct Target Ther. 2022;7:196.","DOI":"10.1038\/s41392-022-01046-3"},{"key":"8412_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol cancer. 2022;21:47.","journal-title":"Mol cancer"},{"key":"8412_CR16","doi-asserted-by":"publisher","first-page":"102006","DOI":"10.1016\/j.redox.2021.102006","volume":"43","author":"G Luis","year":"2021","unstructured":"Luis G, Godfroid A, Nishiumi S, Cimino J, Blacher S, Maquoi E, et al. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biol. 2021;43:102006.","journal-title":"Redox Biol"},{"key":"8412_CR17","doi-asserted-by":"publisher","first-page":"32360","DOI":"10.1074\/jbc.272.51.32360","volume":"272","author":"GV Mallo","year":"1997","unstructured":"Mallo GV, Fiedler F, Calvo EL, Ortiz EM, Vasseur S, Keim V, et al. Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth. J Biol Chem. 1997;272:32360\u20139.","journal-title":"J Biol Chem"},{"key":"8412_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.redox.2018.11.006","volume":"20","author":"MS Narzt","year":"2019","unstructured":"Narzt MS, Nagelreiter IM, Oskolkova O, Bochkov VN, Latreille J, Fedorova M, et al. A novel role for NUPR1 in the keratinocyte stress response to UV oxidized phospholipids. Redox Biol. 2019;20:467\u201382.","journal-title":"Redox Biol"},{"key":"8412_CR19","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1158\/1078-0432.CCR-12-0026","volume":"18","author":"T Hamidi","year":"2012","unstructured":"Hamidi T, Cano CE, Grasso D, Garcia MN, Sandi MJ, Calvo EL, et al. Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death. Clin Cancer Res: J Am Assoc Cancer Res. 2012;18:5234\u201346.","journal-title":"Clin Cancer Res: J Am Assoc Cancer Res"},{"key":"8412_CR20","doi-asserted-by":"publisher","first-page":"e1913","DOI":"10.1038\/cddis.2015.264","volume":"6","author":"LR Palam","year":"2015","unstructured":"Palam LR, Gore J, Craven KE, Wilson JL, Korc M. Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma. Cell Death Dis. 2015;6:e1913.","journal-title":"Cell Death Dis"},{"key":"8412_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35020-3","volume":"8","author":"P Santofimia-Casta\u00f1o","year":"2018","unstructured":"Santofimia-Casta\u00f1o P, Lan W, Bintz J, Gayet O, Carrier A, Lomberk G, et al. Inactivation of NUPR1 promotes cell death by coupling ER-stress responses with necrosis. Sci Rep. 2018;8:16999.","journal-title":"Sci Rep"},{"key":"8412_CR22","doi-asserted-by":"publisher","first-page":"e138117.","DOI":"10.1172\/jci.insight.138117","volume":"5","author":"W Lan","year":"2020","unstructured":"Lan W, Santofimia-Casta\u00a4o P, Swayden M, Xia Y, Zhou Z, Audebert S. et al. ZZW-115-dependent inhibition of NUPR1 nucleartranslocation sensitizes cancer cells to genotoxic agents. JCI insight. 2020;5:e138117.","journal-title":"JCI insight"},{"key":"8412_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20904-2","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Song X, Kuang F, Zhang Q, Xie Y, Kang R, et al. NUPR1 is a critical repressor of ferroptosis. Nat Commun. 2021;12.647.","journal-title":"Nat Commun"},{"key":"8412_CR24","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/iub.271","volume":"61","author":"HO Jin","year":"2009","unstructured":"Jin HO, Seo SK, Woo SH, Choe TB, Hong SI, Kim JI, et al. Nuclear protein 1 induced by ATF4 in response to various stressors acts as a positive regulator on the transcriptional activation of ATF4. IUBMB life. 2009;61:1153\u20138.","journal-title":"IUBMB life"},{"key":"8412_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/gcc.20542","volume":"47","author":"S Veerla","year":"2008","unstructured":"Veerla S, Panagopoulos I, Jin Y, Lindgren D, H\u00f6glund M. Promoter analysis of epigenetically controlled genes in bladder cancer. Genes, Chromosomes Cancer. 2008;47:368\u201378.","journal-title":"Genes, Chromosomes Cancer"},{"key":"8412_CR26","doi-asserted-by":"publisher","first-page":"1313.","DOI":"10.3390\/biom10091313","volume":"10","author":"JL Neira","year":"2020","unstructured":"Neira JL, Rizzuti B, Jim\u201anez-Alesanco A, Palomino-Sch\u201etzlein M, Abi n O, Vel zquez-Campoy A. et al. A Phosphorylation-Induced Switch in the Nuclear Localization Sequence of the Intrinsically Disordered NUPR1 Hampers Binding to Importin. Biomolecules. 2020;10:1313.","journal-title":"Biomolecules"},{"key":"8412_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41419-018-1263-9","volume":"10","author":"J Yu","year":"2019","unstructured":"Yu J, Liu D, Sun X, Yang K, Yao J, Cheng C, et al. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt\/beta-catenin signaling via transactivation of GSK-3beta and Axin2 expression. Cell Death Dis. 2019;10:26.","journal-title":"Cell Death Dis"},{"key":"8412_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41419-019-1441-4","volume":"10","author":"J Yu","year":"2019","unstructured":"Yu J, Li S, Qi J, Chen Z, Wu Y, Guo J, et al. Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells. Cell Death Dis. 2019;10:193.","journal-title":"Cell Death Dis"},{"key":"8412_CR29","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","volume":"82","author":"R Rodriguez","year":"2022","unstructured":"Rodriguez R, Schreiber SL, Conrad M. Persister cancer cells: Iron addiction and vulnerability to ferroptosis. Mol Cell. 2022;82:728\u201340.","journal-title":"Mol Cell"},{"key":"8412_CR30","doi-asserted-by":"publisher","first-page":"e2006203","DOI":"10.1371\/journal.pbio.2006203","volume":"16","author":"H Feng","year":"2018","unstructured":"Feng H, Stockwell BR. Unsolved mysteries: How does lipid peroxidation cause ferroptosis?. PLoS Biol. 2018;16:e2006203.","journal-title":"PLoS Biol"},{"key":"8412_CR31","first-page":"1372","volume":"26","author":"S Arena","year":"2020","unstructured":"Arena S, Corti G, Durinikova E, Montone M, Reilly NM, Russo M, et al. of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin, Clinical cancer research : an official journal of the American Association for. Cancer Res. 2020;26:1372\u201384.","journal-title":"Cancer Res"},{"key":"8412_CR32","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/s41416-018-0285-5","volume":"119","author":"TF Hansen","year":"2018","unstructured":"Hansen TF, Kj\u00e6r-Frifeldt S, Eriksen AC, Lindebjerg J, Jensen LH, S\u00f8rensen FB, et al. Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts. Br J Cancer. 2018;119:1367\u201373.","journal-title":"Br J Cancer"},{"key":"8412_CR33","doi-asserted-by":"crossref","unstructured":"SH den Uil, M de Wit, RJC Slebos, PM Delis-van Diemen, J Sanders, SR Piersma, et al. Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer. Eur J Cancer. 2021;144:91\u2013100.","DOI":"10.1016\/j.ejca.2020.10.029"},{"key":"8412_CR34","first-page":"124","volume":"16","author":"BY Zhang","year":"2017","unstructured":"Zhang BY, Jones JC, Briggler AM, Hubbard JM, Kipp BR, Sargent DJ, et al. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer. Clin colorectal cancer. 2017;16:124\u20138.","journal-title":"Clin colorectal cancer"},{"key":"8412_CR35","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/1878-0261.12347","volume":"12","author":"J Bruun","year":"2018","unstructured":"Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, et al. Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer. Mol Oncol. 2018;12:1639\u201355.","journal-title":"Mol Oncol"},{"key":"8412_CR36","doi-asserted-by":"publisher","first-page":"89160","DOI":"10.18632\/oncotarget.20808","volume":"8","author":"J Yuan","year":"2017","unstructured":"Yuan J, Yin Z, Tao K, Wang G, Gao J. Homeobox protein CDX2 as a prognostic biomarker in solid malignancies: a meta-analysis. Oncotarget. 2017;8:89160\u201372.","journal-title":"Oncotarget"},{"key":"8412_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41379-020-0634-9","volume":"34","author":"KE Hestetun","year":"2021","unstructured":"Hestetun KE, Aaseb\u00f8 K, Rosenlund NB, M\u00fcller Y, Dahl O, Myklebust MP. Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II-III colon cancer. Mod Pathol : Off J U S Can Acad Pathol Inc. 2021;34:161\u201370.","journal-title":"Mod Pathol : Off J U S Can Acad Pathol Inc"},{"key":"8412_CR38","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41379-019-0265-1","volume":"32","author":"C Ma","year":"2019","unstructured":"Ma C, Olevian D, Miller C, Herbst C, Jayachandran P, Kozak MM, et al. SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer. Mod Pathol: Off J U S Can Acad Pathol Inc. 2019;32:1217\u201331.","journal-title":"Mod Pathol: Off J U S Can Acad Pathol Inc"},{"key":"8412_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","volume":"22","author":"ST Diepstraten","year":"2022","unstructured":"Diepstraten ST, Anderson MA, Czabotar PE, Lessene G, Strasser A, Kelly GL. The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs. Nat Rev Cancer. 2022;22:45\u201364.","journal-title":"Nat Rev Cancer"},{"key":"8412_CR40","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","volume":"35","author":"RM Mohammad","year":"2015","unstructured":"Mohammad RM, Muqbil I, Lowe L, Yedjou C, Hsu HY, Lin LT, et al. Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol. 2015;35:S78\u2013s103.","journal-title":"Semin Cancer Biol"},{"key":"8412_CR41","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P. T. Vanden Berghe, Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 2019;35:830\u201349.","journal-title":"Cancer Cell"},{"key":"8412_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2020.02.015","volume":"483","author":"Y Su","year":"2020","unstructured":"Su Y, Zhao B, Zhou L, Zhang Z, Shen Y, Lv H, et al. Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. Cancer Lett. 2020;483:127\u201336.","journal-title":"Cancer Lett"},{"key":"8412_CR43","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03104","volume":"432","author":"TH Flo","year":"2004","unstructured":"Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432:917\u201321.","journal-title":"Nature"},{"key":"8412_CR44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.aaz2193","volume":"369","author":"Y Chi","year":"2020","unstructured":"Chi Y, Remsik J, Kiseliovas V, Derderian C, Sener U, Alghader M, et al. Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis. Sci (NY). 2020;369:276\u201382.","journal-title":"Sci (NY)"},{"key":"8412_CR45","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1053\/j.gastro.2005.01.003","volume":"128","author":"T Hinoi","year":"2005","unstructured":"Hinoi T, Gesina G, Akyol A, Kuick R, Hanash S, Giordano TJ, et al. CDX2-regulated expression of iron transport protein hephaestin in intestinal and colonic epithelium. Gastroenterology. 2005;128:946\u201361.","journal-title":"Gastroenterology"},{"key":"8412_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1385\/ENDO:30:1:81","volume":"30","author":"CM Passe","year":"2006","unstructured":"Passe CM, Cooper G, Quirk CC. The murine p8 gene promoter is activated by activating transcription factor 4 (ATF4) in the gonadotrope-derived LbetaT2 cell line. Endocrine. 2006;30:81\u201391.","journal-title":"Endocrine"},{"key":"8412_CR47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, et al. CD8(\u2009+\u2009) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270\u20134.","journal-title":"Nature"},{"key":"8412_CR48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453\u20137.","journal-title":"Nature"},{"key":"8412_CR49","doi-asserted-by":"crossref","unstructured":"Dai E, Han L, Liu J, Xie Y, Kroemer G, Klionsky DJ, et al. Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy. 2020;16:2069\u201383.","DOI":"10.1080\/15548627.2020.1714209"},{"key":"8412_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20154-8","volume":"11","author":"E Dai","year":"2020","unstructured":"Dai E, Han L, Liu J, Xie Y, Zeh HJ, Kang R, et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173\/STING-dependent DNA sensor pathway. Nat Commun. 2020;11:6339.","journal-title":"Nat Commun"},{"key":"8412_CR51","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41416-020-01148-1","volume":"124","author":"J Yu","year":"2021","unstructured":"Yu J, Li S, Xu Z, Guo J, Li X, Wu Y, et al. CDX2 inhibits epithelial-mesenchymal transition in colorectal cancer by modulation of Snail expression and \u03b2-catenin stabilisation via transactivation of PTEN expression. Br J Cancer. 2021;124:270\u201380.","journal-title":"Br J Cancer"},{"key":"8412_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41419-018-1263-9","volume":"10","author":"J Yu","year":"2019","unstructured":"Yu J, Liu D, Sun X, Yang K, Yao J, Cheng C, et al. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt\/\u03b2-catenin signaling via transactivation of GSK-3\u03b2 and Axin2 expression. Cell Death Dis. 2019;10:26.","journal-title":"Cell Death Dis"},{"key":"8412_CR53","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/carcin\/bgp213","volume":"31","author":"RJ Guo","year":"2010","unstructured":"Guo RJ, Funakoshi S, Lee HH, Kong J, Lynch JP. The intestine-specific transcription factor Cdx2 inhibits beta-catenin\/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex. Carcinogenesis. 2010;31:159\u201366.","journal-title":"Carcinogenesis"},{"key":"8412_CR54","doi-asserted-by":"publisher","first-page":"36865","DOI":"10.1074\/jbc.M405213200","volume":"279","author":"RJ Guo","year":"2004","unstructured":"Guo RJ, Huang E, Ezaki T, Patel N, Sinclair K, Wu J, et al. Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin\/T-cell factor transcriptional activity, The. J Biol Chem. 2004;279:36865\u201375.","journal-title":"J Biol Chem"},{"key":"8412_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/labinvest.2015.137","volume":"96","author":"Y Tamagawa","year":"2016","unstructured":"Tamagawa Y, Ishimura N, Uno G, Aimi M, Oshima N, Yuki T, et al. Bile acids induce Delta-like 1 expression via Cdx2-dependent pathway in the development of Barrett\u2019s esophagus. Lab Investig; a J Tech methods Pathol. 2016;96:325\u201337.","journal-title":"Lab Investig; a J Tech methods Pathol"},{"key":"8412_CR56","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/carcin\/bgaa083","volume":"41","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Seo EH, Bae DH, Haam K, Jang HR, Park JL, et al. Methylation of the CDX2 promoter in Helicobacter pylori-infected gastric mucosa increases with age and its rapid demethylation in gastric tumors is associated with upregulated gene expression. Carcinogenesis. 2020;41:1341\u201352.","journal-title":"Carcinogenesis"},{"key":"8412_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16840-2","volume":"11","author":"T Vu","year":"2020","unstructured":"Vu T, Straube J, Porter AH, Bywater M, Song A, Ling V, et al. Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia. Nat Commun. 2020;11:3021.","journal-title":"Nat Commun"},{"key":"8412_CR58","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1093\/nar\/gkr1242","volume":"40","author":"B Renouf","year":"2012","unstructured":"Renouf B, Soret C, Saandi T, Delalande F, Martin E, Vanier M, et al. Cdx2 homeoprotein inhibits non-homologous end joining in colon cancer but not in leukemia cells. Nucleic acids Res. 2012;40:3456\u201369.","journal-title":"Nucleic acids Res"},{"key":"8412_CR59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bbadis.2010.11.008","volume":"1812","author":"M Coskun","year":"2011","unstructured":"Coskun M, Troelsen JT, Nielsen OH. The role of CDX2 in intestinal homeostasis and inflammation. Biochimica et biophysica acta. 2011;1812:283\u20139.","journal-title":"Biochimica et biophysica acta"},{"key":"8412_CR60","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1200\/JCO.22.01420","volume":"41","author":"S Stintzing","year":"2023","unstructured":"Stintzing S, Heinrich K, Tougeron D, Modest DP, Schwaner I, Eucker J, et al. FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF(V600E)-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study. J Clin Oncol: J Am Soc Clin Oncol. 2023;41:4143\u201353.","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08412-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08412-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08412-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:02:17Z","timestamp":1774987337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08412-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8412"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08412-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"7 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments in this study were performed in compliance with the guidelines of the Declaration of Helsinki and approved by the Institutional Animal Care and Use Committee (IACUC) of The First Affiliated Hospital of Xi\u2019an Jiaotong University. For human specimen-related research, patients were fully informed that their resected tissues would be archived by the hospital for potential scientific use, with strict safeguards for their privacy. Written informed consent was obtained from all patients prior to surgery, and the study protocol was approved by the Ethics Committee of the above-mentioned hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"308"}}